Kallmann Syndrome and Depression: A Case Report

Authors

DOI:

https://doi.org/10.30834/KJP.38.1.2025.509

Keywords:

Kallmann syndrome, Hypogonadotrophic hypogonadism, Testosterone, Depression

Abstract

Kallmann syndrome is a genetic condition that causes low testosterone levels and anosmia. It can also be linked to mood disorders such as depression. This case report describes an 18-year-old male with Kallmann syndrome who experienced low mood, fatigue, irritability, and sleep disturbances. He was receiving testosterone therapy and was started on Escitalopram and Clonazepam for depression. His symptoms initially improved, but after stopping both testosterone and antidepressants, his depression returned. Restarting Escitalopram led to symptom improvement. This case highlights the need for regular psychiatric evaluation in patients with Kallmann syndrome, as stopping treatment can lead to a relapse of depressive symptoms. Early recognition and proper management can improve patient well-being.

Downloads

Download data is not yet available.

References

Laitinen EM, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, Valanne L, et al. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. Orphanet J Rare Dis. 2011 Jun 17; 6: 41.

Baulieu EE, Robel P, Schumacher M. Neurosteroids: Beginning of the story. In: International Review of Neurobiology. 2001; 46:1-32.

Dodé C, Hardelin JP. Kallmann syndrome. Eur J Hum Genet. 2009 Feb;17(2):139-46.

Verhoeven WMA, Egger JIM, Hovens JE, Hoefsloot L. Kallmann syndrome and paranoid schizophrenia: a rare combination. BMJ Case Rep. 2013 Mar 1; 2013: bcr2012007387.

Hofmann J, Watzlawik M, Richter-Appelt H. Living with Kallmann syndrome – analysis of subjective experience reports from women. Geburtshilfe Frauenheilkd. 2013 Nov;73(11):1112-20.

Indirli R, Lanzi V, Arosio M, Mantovani G, Ferrante E. The association of hypogonadism with depression and its treatments. Front Endocrinol (Lausanne). 2023 Sep 8; 14:1198437.

Hardelin JP, Soussi-Yanicostas N, Ardouin O, Levilliers J, Petit C. Kallmann syndrome. Adv Otorhinolaryngol. 2000; 55:268-74.

Sonne J, Lopez-Ojeda W. Kallmann Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. PMID: 29939667.

McHenry J, Carrier N, Hull E, Kabbaj M. Sex differences in anxiety and depression: Role of testosterone. Front Neuroendocrinol. 2014 Jan;35(1):42-57.

Dwyer AA. Psychosexual effects resulting from delayed, incomplete, or absent puberty. Curr Opin Endocr Metab Res. 2020 Oct; 14:15-21.

Boland R, Verduin ML, Ruiz P. Kaplan & Sadock's Synopsis of Psychiatry, 12e. Lippincott Williams & Wilkins, a Wolters Kluwer business; 2022. Accessed January 27, 2025.

Downloads

Published

29-05-2025

How to Cite

Tanvi Mittal, and Nishanth JH. “Kallmann Syndrome and Depression: A Case Report”. Kerala Journal of Psychiatry, vol. 38, no. 1, May 2025, pp. 62-64, doi:10.30834/KJP.38.1.2025.509.

Issue

Section

Case Report